Correlation Between China Communications and SCANDMEDICAL SOLDK-040

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both China Communications and SCANDMEDICAL SOLDK-040 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China Communications and SCANDMEDICAL SOLDK-040 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China Communications Services and SCANDMEDICAL SOLDK 040, you can compare the effects of market volatilities on China Communications and SCANDMEDICAL SOLDK-040 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China Communications with a short position of SCANDMEDICAL SOLDK-040. Check out your portfolio center. Please also check ongoing floating volatility patterns of China Communications and SCANDMEDICAL SOLDK-040.

Diversification Opportunities for China Communications and SCANDMEDICAL SOLDK-040

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between China and SCANDMEDICAL is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding China Communications Services and SCANDMEDICAL SOLDK 040 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCANDMEDICAL SOLDK 040 and China Communications is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China Communications Services are associated (or correlated) with SCANDMEDICAL SOLDK-040. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCANDMEDICAL SOLDK 040 has no effect on the direction of China Communications i.e., China Communications and SCANDMEDICAL SOLDK-040 go up and down completely randomly.

Pair Corralation between China Communications and SCANDMEDICAL SOLDK-040

Assuming the 90 days horizon China Communications Services is expected to generate 0.69 times more return on investment than SCANDMEDICAL SOLDK-040. However, China Communications Services is 1.46 times less risky than SCANDMEDICAL SOLDK-040. It trades about 0.11 of its potential returns per unit of risk. SCANDMEDICAL SOLDK 040 is currently generating about -0.04 per unit of risk. If you would invest  48.00  in China Communications Services on October 16, 2024 and sell it today you would earn a total of  3.00  from holding China Communications Services or generate 6.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

China Communications Services  vs.  SCANDMEDICAL SOLDK 040

 Performance 
       Timeline  
China Communications 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days China Communications Services has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, China Communications is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.
SCANDMEDICAL SOLDK 040 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SCANDMEDICAL SOLDK 040 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, SCANDMEDICAL SOLDK-040 is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

China Communications and SCANDMEDICAL SOLDK-040 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with China Communications and SCANDMEDICAL SOLDK-040

The main advantage of trading using opposite China Communications and SCANDMEDICAL SOLDK-040 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China Communications position performs unexpectedly, SCANDMEDICAL SOLDK-040 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCANDMEDICAL SOLDK-040 will offset losses from the drop in SCANDMEDICAL SOLDK-040's long position.
The idea behind China Communications Services and SCANDMEDICAL SOLDK 040 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope